Susceptibility to adverse drug reactions

被引:27
作者
Ferner, Robin [1 ,2 ]
Aronson, Jeffrey [1 ,3 ]
机构
[1] City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England
[2] Univ Birmingham, Inst Clin Sci, Birmingham, W Midlands, England
[3] Nuffield Dept Primary Care Hlth Sci, Ctr Evidence Based Med, Oxford, England
关键词
adverse drug reactions; pharmacodynamics; pharmacokinetics; genetic polymorphisms; prescribing; INDUCED LIVER-INJURY; MASS-ACTION; REPRODUCTIVE AGE; RISK-FACTORS; LAW; HYPERSENSITIVITY; ANAPHYLAXIS; SENSITIVITY; INHIBITORS; REACTIVITY;
D O I
10.1111/bcp.14015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pharmacological effects of a drug depend on its concentration at the site of action, and therefore on the concentration in blood and on the dose. The relationship between the concentration or dose and the corresponding effect can usually be represented mathematically as a rectangular hyperbola; when effect is plotted against log concentration or log dose, the curve is sigmoidal. Inevitably, the effect size and the doses causing benefit and harm will differ among individuals, since they are biological phenomena: some individuals are more likely than others to suffer harm at any given dose. Some harmful effects can occur at much lower doses than those used in therapeutics; that is, the log dose-response curve for harm lies far to the left of the log dose-response curve for benefit. Those who suffer such reactions are hypersusceptible. When the dose-response curves for harm and therapeutic effect are in the same range, dose cannot separate the harmful effects from the therapeutic effects, and adverse reactions are collateral. Toxic effects occur when harmful doses are above the doses needed for benefit. In this review we consider factors that influence a subject's susceptibility to adverse drug reactions. Determinants of susceptibility include Immunological, Genetic, demographic (Age and Sex), Physiological and Exogenous factors (drug-drug interactions, for example), and Diseases and disorders such as renal failure, giving the mnemonic I GASPED. Some susceptibility factors are discrete (for example, all-or-none) and some are continuous; susceptibility can therefore be discrete or continuous; and the factors can interact to determine a person's overall susceptibility to harm.
引用
收藏
页码:2205 / 2212
页数:8
相关论文
共 50 条
[31]   Cutaneous adverse drug reactions [J].
Lebrun-Vignes, B. ;
Valeyrie-Allanore, L. .
REVUE DE MEDECINE INTERNE, 2015, 36 (04) :256-270
[32]   Genomics of Adverse Drug Reactions [J].
Alfirevic, Ana ;
Pirmohamed, Munir .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2017, 38 (01) :100-109
[33]   Analysis of Adverse Drug Reactions in Pediatric Patients with Epilepsy: An Intensive Pharmacovigilance Study [J].
Hernandez Garcia, Ernestina ;
Naranjo, Lizbeth ;
Pichardo-Macias, Luz Adriana ;
Bernad Bernad, Maria Josefa ;
Castro-Pastrana, Lucila Isabel ;
Ruiz Garcia, Matilde ;
Garcia Bernal, Tanya Alejandra ;
Solis, Jessica Lizbeth Mendoza ;
Guzman, David Calderon ;
Diaz-Garcia, Luisa ;
Mendoza-Torreblanca, Julieta Griselda ;
Chavez Pacheco, Juan Luis .
CHILDREN-BASEL, 2023, 10 (11)
[34]   Genetics of Immune-Mediated Adverse Drug Reactions: a Comprehensive and Clinical Review [J].
Yip, V. L. M. ;
Alfirevic, A. ;
Pirmohamed, M. .
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2015, 48 (2-3) :165-175
[35]   The Risk of Adverse Drug Reactions in Older Patients: Beyond Drug Metabolism [J].
Onder, Graziano ;
Lattanzio, Fabrizia ;
Battaglia, Miriam ;
Cerullo, Francesco ;
Sportiello, Roberta ;
Bernabei, Roberto ;
Landi, Francesco .
CURRENT DRUG METABOLISM, 2011, 12 (07) :647-651
[36]   HLA-associated drug hypersensitivity and the prediction of adverse drug reactions [J].
Negrini, Simone ;
Becquemont, Laurent .
PHARMACOGENOMICS, 2017, 18 (15) :1441-1457
[37]   Dentistry adverse drug reactions and drug interactions [J].
Decani, S. ;
Baruzzi, E. ;
Martini, V. ;
Ficarra, G. ;
Lodi, G. .
DENTAL CADMOS, 2013, 81 (03) :125-135
[38]   Polypharmacology of clinical sodium glucose co-transport protein 2 inhibitors and relationship to suspected adverse drug reactions [J].
Matharu, Karan ;
Chana, Kiran ;
Ferro, Charles J. ;
Jones, Alan M. .
PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (05)
[39]   Adverse drug reactions in older people: Detection and prevention [J].
Mirko Petrovic ;
Tischa van der Cammen ;
Graziano Onder .
Drugs & Aging, 2012, 29 (6) :453-462
[40]   An update on adverse drug reactions related to -lactam antibiotics [J].
Vardakas, Konstantinos Z. ;
Kalimeris, Georgios D. ;
Triarides, Nikolaos A. ;
Falagas, Matthew E. .
EXPERT OPINION ON DRUG SAFETY, 2018, 17 (05) :499-508